SPONSOR
Istituto Clinico Humanitas
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Bloodstream InfectionGram-Negative InfectionsGram-Positive InfectionsBacteremia SepsisDiffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma (HGBCL)B-Cell Lymphoma TreatmentRelapsed or Refractory LymphomaCancerPreeclampsia
Istituto Clinico Humanitas is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Bloodstream Infection, Gram-Negative Infections, Gram-Positive Infections, Bacteremia Sepsis.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Istituto Clinico Humanitas
How many clinical trials has Istituto Clinico Humanitas sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Istituto Clinico Humanitas, of which 4 are actively recruiting participants. These trials cover conditions including Bloodstream Infection, Gram-Negative Infections, Gram-Positive Infections. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Istituto Clinico Humanitas research focus on?
Istituto Clinico Humanitas clinical trials span Bloodstream Infection, Gram-Negative Infections, Gram-Positive Infections, Bacteremia Sepsis, Diffuse Large B-Cell Lymphoma, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Istituto Clinico Humanitas clinical trial?
To participate in a Istituto Clinico Humanitas trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Istituto Clinico Humanitas trials with current recruitment status updated daily.
Clinical Trials by Istituto Clinico Humanitas
NCT07491419
Recruiting
The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)
Bloodstream Infection
NCT06918912 Phase 2
Recruiting
Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure
Diffuse Large B-Cell Lymphoma
NCT07098247
Recruiting
Exploring Photon-Counting CT for Enhanced Target Delineation and Dose Accuracy in Personalized Radiotherapy - ANTHEM
Cancer
NCT06430398
Recruiting
A Novel Multiomic AI Approach for Early Preeclampsia Prediction in Pregnancy
Preeclampsia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology